Infutraze concentrate for solution for infusion

Licence status
Authorised: 30/06/2023
Active substances
Copper chloride dihydrate, Manganese chloride tetrahydrate, Potassium iodide, Sodium selenite anhydrous, Zinc chloride
Dosage Form
Concentrate for solution for infusion
Licence number
PA2059/083/001
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
B05XA31 electrolytes in combination with other drugs
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
30/06/2023